Skip to main content

Table 1 The details of enrolled samples from ADNI database

From: Impacts of CR1 genetic variants on cerebrospinal fluid and neuroimaging biomarkers in alzheimer’s disease

Characteristics

NC

AD

N

Mean ± SD

 

Mean ± SD

Age (years)

281

74.51 ± 5.56

48

75.51 ± 9.23

Gender (male/female)

281

136/145

48

30/18

Education (years)

281

16.41 ± 2.66

48

15.73 ± 2.62

ApoE ε4 (0/1/2)

281

204/70/7

48

14/25/9

CDRSB (scores)

207

6.54 ± 0.55

47

5.3 ± 0.72

ADAS (scores)

281

29.07 ± 1.15

48

22.96 ± 2.03

MMSE (scores)

281

9.06 ± 4.23

48

29.8 ± 8.44

RAVLT total (scores)

280

44.83 ± 9.6

47

22.32 ± 7.84

FAQ (scores)

281

0.17 ± 0.66

48

12.6 ± 7.14

  1. ADNI alzheimer’s disease neuroimaging initiative, AD alzheimer’s disease, ApoE ε4 apolipoprotein E ε4, SD standard deviations, ADAS alzheimer’s disease assessment scale, CDRSB clinical dementia rating scale sum of boxes, FAQ functional activities questionnaire, MMSE mini-mental state exam, NC normal controls, RAVLT rey auditory verbal learning test